Welcome to our dedicated page for Assertio Holdings SEC filings (Ticker: ASRT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Assertio Holdings, Inc. (ASRT) provides direct access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents offer detailed information about Assertio’s operations as a pharmaceutical company focused on oncology, neurology, and pain management, and they complement the company’s press releases and investor presentations.
Through this page, readers can review current reports on Form 8-K, where Assertio reports material events such as leadership transitions, executive appointments, supply and licensing agreements, and financial results announcements. For example, recent 8-K filings describe the appointment of a new Chief Executive Officer, the promotion of a President and Chief Operating Officer, and the separation of a former CEO, along with associated management continuity and compensation arrangements.
Filings also document capital markets and listing-related actions, including disclosure of Assertio’s common stock listing on The Nasdaq Stock Market LLC under the symbol ASRT and the implementation of a 1-for-15 reverse stock split of its issued and outstanding common stock. These records provide historical context for Nasdaq listing compliance and changes to the company’s capital structure.
Investors can use Assertio’s SEC filings to understand supply and product agreements, such as amendments to long-term supply contracts for Rolvedon drug substance through its subsidiary Spectrum Pharmaceuticals, Inc., including pricing terms and forecasting obligations. The filings also reference press releases that contain financial results, guidance updates, and strategic commentary.
On Stock Titan, SEC documents are paired with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly identify topics like quarterly performance (10-Q), annual reporting (10-K), and material 8-K events. The platform also surfaces insider and executive-related disclosures, allowing users to follow governance changes and compensation arrangements without reading every line of each filing.
Schlessinger Sam reported acquisition or exercise transactions in this Form 4 filing.
Assertio Holdings EVP and General Counsel Sam Schlessinger received new equity awards. On the reported date, he was granted 18,804 restricted stock units and 21,128 stock options, each RSU representing one share of common stock. One-third of both awards vest on each of the first three anniversaries of the grant date, subject to continued employment, and no cash consideration was paid for these grants.
Assertio Holdings, Inc. reported that EVP and CFO Ajay Patel acquired equity awards consisting of restricted stock units and stock options. He received 18,804 restricted stock units, each representing a right to receive one share of common stock, and 21,128 stock options.
One-third of both the restricted stock units and the stock options are scheduled to vest on each of the first three anniversaries of the March 2, 2026 grant date, assuming continued employment through each vesting date. The awards were granted for no cash consideration, so Patel did not pay to receive these derivative securities.
Assertio Holdings, Inc.
Reisenauer Mark L reported acquisition or exercise transactions in this Form 4 filing.
Assertio Holdings CEO Mark L. Reisenauer received a grant of 26,667 stock options on March 2, 2026. These derivative securities were awarded at no cost to him and give the right to buy Assertio common stock.
One-third of the options will vest on each of the first three anniversaries of the grant date, assuming he remains employed through each vesting date. The reported amounts have been adjusted to reflect a 1-for-15 reverse stock split that occurred on December 26, 2025.
Assertio Holdings EVP and General Counsel Sam Schlessinger reported routine equity compensation activity. He exercised and settled 1,143 restricted stock units into the same number of common shares at $0.00 per share, then had 510 common shares withheld at $11.84 per share to cover taxes. After these transactions, he directly owned 14,738 shares of Assertio common stock.
Assertio Holdings EVP and CFO Ajay Patel reported equity award transactions involving restricted stock units and common stock. On February 21, 2026, 1,143 restricted stock units were converted into 1,143 shares of common stock at a stated price of $0.00 per share, reflecting settlement of vested units. In a related move, 566 shares of common stock were withheld at $11.84 per share to cover tax obligations upon vesting, leaving Patel with 15,942 shares of common stock held directly after these transactions. The restricted stock units were granted at no cost and vest in three equal installments on February 21 of 2024, 2025 and 2026, subject to continued employment.
Assertio Holdings, Inc. President and COO Paul Schwichtenberg reported equity compensation activity involving restricted stock units and common stock. He exercised 1,143 restricted stock units, which converted into 1,143 shares of common stock at a price of
Of the resulting common shares, 566 were withheld at
The restricted stock units vest in three equal installments on
Assertio Holdings, Inc. executive vice president and general counsel Sam Schlessinger reported equity award activity involving restricted stock units and common stock. On February 18, 2026, he exercised 2,778 restricted stock units, which settled into 2,778 shares of common stock at no cash cost, reflecting the conversion of previously granted derivative securities.
In a related move, 1,239 common shares were withheld on the same date to cover tax obligations upon vesting, at a reported price of
Assertio Holdings, Inc. President and COO Paul Schwichtenberg reported equity award activity involving restricted stock units (RSUs) and common stock. He acquired 2,778 RSUs through a derivative exercise and, in a corresponding move, received 2,778 shares of common stock at a stated price of
Assertio Holdings EVP and CFO Ajay Patel reported equity award activity involving restricted stock units (RSUs) and common stock. On February 18, 2026, 2,778 RSUs were settled into 2,778 shares of common stock at $0.00 per share, reflecting a derivative exercise/conversion. To cover tax obligations upon vesting, 1,377 shares of common stock were withheld at $11.87 per share, reducing his directly held common stock to 15,365 shares. Following these transactions, Patel also held 5,555 RSUs directly, with one-third scheduled to vest on each of February 18, 2026, 2027 and 2028, assuming continued employment.